Insider · CIK 0001402652
GRANDE ALICIA
Reports to the SEC for 1 company · CORAL GABLES, FL
Transactions
50
Companies
1
Filings
3
CIK
0001402652
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-12-27 | CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2023-12-27 | CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion | — |
| 2023-12-27 | CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment | — |
| 2023-12-11 | CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion | +$67.8K |
| 2023-12-11 | CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion | — |
| 2023-12-11 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$414K |
| 2023-12-11 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$412K |
| 2023-12-08 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$285K |
| 2023-12-08 | CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion | — |
| 2023-12-08 | CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion | +$45.2K |
| 2023-12-08 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$286K |
| 2023-03-29 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$167K |
| 2023-03-29 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$334K |
| 2023-03-29 | CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion | +$56.5K |
| 2023-03-29 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$334K |
| 2023-03-29 | CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion | — |
| 2023-03-28 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$166K |
| 2023-03-28 | CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion | — |
| 2023-03-28 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$165K |
| 2023-03-28 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$468K |
| 2023-03-28 | CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion | +$46K |
| 2023-03-28 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$164K |
| 2023-03-22 | CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion | — |
| 2023-03-22 | CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion | +$2,575.4 |
| 2023-03-22 | CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion | +$30.4K |
| 2023-03-22 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$53.5K |
| 2023-03-22 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$636K |
| 2023-03-22 | CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion | — |
| 2023-02-15 | CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2023-02-15 | CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment | — |
| 2023-02-15 | CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion | — |
| 2022-12-27 | CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award | — |
| 2022-12-27 | CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award | — |
| 2022-12-06 | CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion | — |
| 2022-12-06 | CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2022-11-22 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$1.98M |
| 2022-11-15 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$946K |
| 2022-09-23 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$714K |
| 2022-09-16 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$1.21M |
| 2022-09-14 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$779K |
| 2022-08-29 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$284K |
| 2022-08-29 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$283K |
| 2022-08-29 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$243K |
| 2022-08-26 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$160K |
| 2022-08-18 | CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion | — |
| 2022-08-18 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$264K |
| 2022-08-18 | CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion | +$48.7K |
| 2022-08-17 | CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion | +$251K |
| 2022-08-17 | CPRXCATALYST PHARMACEUTICALS, INC.S Sale | −$1.38M |
| 2022-08-17 | CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion | +$79.5K |
Recent filings
- 4GRANDE ALICIA0001161697-23-000646SEC(opens sec.gov)
- 4GRANDE ALICIA0001161697-23-000610SEC(opens sec.gov)
- 4GRANDE ALICIA0001161697-23-000200SEC(opens sec.gov)
Companies
Address
355 ALHAMBRA CIRCLE SUITE 1370
CORAL GABLES, FL, 33134